推荐产品
ligand
alkali-stabilized protein A-derived (E. coli)
包裝
pack of 200 mL
製造商/商標名
Cytiva 17-5438-02
儲存條件
(20% Ehtanol)
基質
highly cross-linked agarose
樣品平均尺寸
85 μm (d₅₀v is the median particle size of the cumulative volume distribution)
cleaning in place
2-13.7
工作範圍
3-12
容量
≥30 mg binding capacity (humanlgG/ml at 2.4 min residence time)
適合性
suitable for bioprocess medium
儲存溫度
2-8°C
一般說明
MabSelect™ SuRe™ is a member of the MabSelect™ family of affinity chromatography media for the capture of monoclonal antibodies (MAbs) at process scale. MabSelect™ SuRe™ shares features and benefits of MabSelect™ such as a rigid, high-flow agarose matrix that ensures excellent pressure/flow properties, low non-specific binding that leads to low impurity levels in the eluate pool, and an oriented ligand coupling for optimal binding capacity. In addition, MabSelect™ SuRe™ features an alkali-tolerant rProtein A ligand. This ligand provides greater stability than conventional protein A-based media in the alkaline conditions used in cleaning-in-place (CIP) and sanitization protocols. The enhanced alkali stability of MabSelect™ SuRe™ improves process economy and product quality; cleaning can be performed with cost-effective reagents such as sodium hydroxide eliminating the need for expensive and hazardous cleaning agents such as Gua-HCl.
The novel ligand construct of MabSelect™ SuRe™ has been proven to have an increased stability towards proteases. Therefore, the level of leakage of the MabSelect™ SuRe™ ligand during elution is low. MabSelect™ SuRe™ has been demonstrated to give generic elution conditions for different monoclonal antibodies, which is an advantage when designing generic purification platform processes. This feature is also correlated to the construction of the MabSelect™ SuRe™ ligand.
MabSelect™ SuRe™ is available in a range of different bulk pack sizes and convenient pre-packed formats for easy scale-up and process development. As member of the BioProcess media range, MabSelect™ SuRe™ meets industrial demands with security of supply and comprehensive technical and regulatory support.
特點和優勢
- Novel, alkali-tolerant rProtein A ligand withstands rigorous CIP and sanitization procedures with 0.1 to 0.5 M NaOH.
- Reduces the risk of product contamination and carryover
- Improves product quality and reduces overall costs
- Novel ligand design gives enhanced protease resistance resulting in lower ligand leakage
- Generic elution profile for different monoclonal antibodies enables platform approach to purification
- Used in the commercial manufacture of monoclonal antibodies
- High-flow agarose matrix allows the processing of large feed volumes
儲存和穩定性
分析報告
法律資訊
"MabSelect SuRe Ligand Restricted License" and "Cys-rProtein A Ligand Restricted License" are protected by the following patents and equivalent patents and patent applications in other countries: US 6,399,750 and EP 1123389. A free, non-transferable limited license to use this product for internal analytical purposes only accompanies the purchase of the product from a Cytiva company and its licensed distributors. Any other use will require a separate license from a Cytiva company.
訊號詞
Warning
危險聲明
儲存類別代碼
3 - Flammable liquids
其他客户在看
商品
Description of viral clearance using Capto adhere from GE Healthcare.
Description of viral clearance using Capto adhere from GE Healthcare.
Capto adhere from GE Healthcare is a multimodal strong anion exchanger for BioProcess applications.
This page describes the difference between bind/elute and flowthrough modes in multimodal chromatography using GE Healthcare products.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门